M
Marco Cattaneo
Researcher at University of Milan
Publications - 408
Citations - 21464
Marco Cattaneo is an academic researcher from University of Milan. The author has contributed to research in topics: Platelet & Clopidogrel. The author has an hindex of 77, co-authored 392 publications receiving 19572 citations. Previous affiliations of Marco Cattaneo include Spanish National Research Council & University of Arkansas for Medical Sciences.
Papers
More filters
Journal ArticleDOI
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
Jecko Thachil,Ning Tang,Satoshi Gando,Anna Falanga,Marco Cattaneo,Marcel Levi,Cary Clark,Toshiaki Iba +7 more
TL;DR: This work aims to contribute towards the humanizing of thrombosis and Haemostasis by promoting awareness of the importance of proper diagnosis and treatment of these conditions in patients.
Journal ArticleDOI
Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
Laurent Bonello,Udaya S. Tantry,Rossella Marcucci,Ruediger Blindt,Dominick J. Angiolillo,Richard C. Becker,Deepak L. Bhatt,Marco Cattaneo,Jean-Philippe Collet,Thomas Cuisset,Christian Gachet,Gilles Montalescot,Lisa K. Jennings,Dean J. Kereiakes,Dirk Sibbing,Dietmar Trenk,Jochem W. van Werkum,Franck Paganelli,Matthew J. Price,Ron Waksman,Paul A. Gurbel +20 more
TL;DR: A consensus opinion is provided on the definition of high on-treatment platelet reactivity to ADP based on various methods reported in the literature and how this measurement may be used in the future care of patients.
Journal ArticleDOI
Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.
Piera Angelica Merlini,Kenneth A. Bauer,Luigi Oltrona,Diego Ardissino,Marco Cattaneo,Carlo Belli,Pier Mannuccio Mannucci,Robert D. Rosenberg +7 more
TL;DR: Over the next 6 months, patients with unstable angina or myocardial infarction experiencing an uneventful clinical course manifest a persistent hypercoagulable state with minimal generation of fibrin.
Journal ArticleDOI
Aspirin and clopidogrel: Efficacy, safety, and the issue of drug resistance
TL;DR: “Aspirin-resistant” should be considered as a description for those individuals in whom aspirin fails to inhibit thromboxane A2 production, irrespective of the results of unspecific tests of platelet function, such as the bleeding time, platelet aggregation, or the PFA-100 system.
Journal ArticleDOI
Recommendations for the standardization of light transmission aggregometry : a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH
Marco Cattaneo,Chiara Cerletti,Paul Harrison,Catherine P.M. Hayward,Dermot Kenny,Diane J. Nugent,Paquita Nurden,A. K. Rao,Alvin H. Schmaier,Steve P. Watson,Federico Lussana,Mariateresa Pugliano,Alan D. Michelson +12 more
TL;DR: The Platelet Physiology Subcommittee of the Scientific and Standardization Committee (SSC) of the International Society on Thrombosis and Haemostasis formed a working party of experts with the aim of producing a series of consensus recommendations for standardizing LTA, which formed the basis of a consensus document, which is the subject of the present report.